| Development of benzimidazole-based derivatives as antimicrobial agents and their synergistic effect with colistin against gram-negative bacteria EME Dokla, NS Abutaleb, SN Milik, D Li, K El-Baz, MAW Shalaby, ... European journal of medicinal chemistry 186, 111850, 2020 | 56 | 2020 |
| How to train your inhibitor: Design strategies to overcome resistance to Epidermal Growth Factor Receptor inhibitors SN Milik, DS Lasheen, RAT Serya, KAM Abouzid European journal of medicinal chemistry 142, 131-151, 2017 | 56 | 2017 |
| Surmounting the resistance against EGFR inhibitors through the development of thieno [2, 3-d] pyrimidine-based dual EGFR/HER2 inhibitors SN Milik, AK Abdel-Aziz, DS Lasheen, RAT Serya, S Minucci, ... European journal of medicinal chemistry 155, 316-336, 2018 | 51 | 2018 |
| Discovery of a benzimidazole-based dual FLT3/TrKA inhibitor targeting acute myeloid leukemia EME Dokla, AK Abdel-Aziz, SN Milik, MJ McPhillie, S Minucci, ... Bioorganic & medicinal chemistry 56, 116596, 2022 | 12 | 2022 |
| SAR investigation and optimization of benzimidazole-based derivatives as antimicrobial agents against Gram-negative bacteria EME Dokla, NS Abutaleb, SN Milik, EAEA Kandil, OM Qassem, ... European Journal of Medicinal Chemistry 247, 115040, 2023 | 10 | 2023 |
| Indolin-2-one derivatives as selective Aurora B kinase inhibitors targeting breast cancer EME Dokla, AK Abdel-Aziz, SN Milik, AH Mahmoud, MK Saadeldin, ... Bioorganic Chemistry 117, 105451, 2021 | 6 | 2021 |
| Insights into the design of inhibitors of the EGFR family with anticancer activity overcoming resistance: A case of optimizing thieno [2, 3-d] pyrimidine-based EGFR inhibitors SN Milik, AK Abdel-Aziz, MM El-Hendawy, RI El-Gogary, MK Saadeldin, ... Journal of Molecular Structure 1259, 132724, 2022 | 5 | 2022 |
| Broadening the spectrum of oxazolidinone antibacterial drugs to encompass Gram-negative bacteria SNM Milik University of Leeds, 2023 | | 2023 |
Khaled Abouzidprofessor of pharmaceutical chemistry在 pharma.asu.edu.eg 的电子邮件经过验证
